Insufficient scRNA-seq data for expression of APOBEC3D at single-cell level.
Insufficient scRNA-seq data for expression of APOBEC3D at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 232.98 | 577 / 578 | 21% | 0.32 | 239 / 1155 |
ovary | 100% | 292.79 | 180 / 180 | 17% | 0.26 | 73 / 430 |
kidney | 97% | 144.54 | 86 / 89 | 19% | 0.28 | 168 / 901 |
uterus | 100% | 250.79 | 170 / 170 | 14% | 0.21 | 66 / 459 |
stomach | 98% | 155.98 | 353 / 359 | 15% | 0.23 | 44 / 286 |
bladder | 100% | 221.24 | 21 / 21 | 13% | 0.19 | 63 / 504 |
skin | 89% | 86.87 | 1605 / 1809 | 23% | 0.36 | 109 / 472 |
thymus | 99% | 179.90 | 647 / 653 | 10% | 0.14 | 58 / 605 |
intestine | 99% | 242.97 | 961 / 966 | 8% | 0.12 | 42 / 527 |
esophagus | 94% | 96.08 | 1362 / 1445 | 13% | 0.18 | 24 / 183 |
breast | 98% | 158.35 | 448 / 459 | 9% | 0.13 | 102 / 1118 |
adrenal gland | 100% | 191.37 | 257 / 258 | 2% | 0.02 | 4 / 230 |
prostate | 100% | 258.97 | 244 / 245 | 1% | 0.01 | 4 / 502 |
spleen | 100% | 1081.83 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 635.94 | 921 / 929 | 0% | 0 | 0 / 0 |
adipose | 97% | 147.38 | 1164 / 1204 | 0% | 0 | 0 / 0 |
heart | 83% | 64.22 | 717 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 82% | 75.00 | 1096 / 1335 | 0% | 0 | 0 / 0 |
liver | 69% | 45.79 | 157 / 226 | 3% | 0.05 | 14 / 406 |
lymph node | 0% | 0 | 0 / 0 | 62% | 1.32 | 18 / 29 |
tonsil | 0% | 0 | 0 / 0 | 44% | 0.82 | 20 / 45 |
pancreas | 31% | 17.17 | 102 / 328 | 10% | 0.13 | 17 / 178 |
brain | 25% | 12.83 | 673 / 2642 | 0% | 0.00 | 1 / 705 |
muscle | 16% | 7.76 | 131 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.13 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051607 | Biological process | defense response to virus |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0016554 | Biological process | cytidine to uridine editing |
GO_0044355 | Biological process | clearance of foreign intracellular DNA |
GO_0070383 | Biological process | DNA cytosine deamination |
GO_0009972 | Biological process | cytidine deamination |
GO_0045087 | Biological process | innate immune response |
GO_0000932 | Cellular component | P-body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004126 | Molecular function | cytidine deaminase activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | APOBEC3D |
Protein name | DNA dC->dU-editing enzyme APOBEC-3D (A3D) (A3DE) (EC 3.5.4.38) Apolipoprotein B mRNA editing enzyme catalytic subunit 3D (BK150C2.9 protein) (HCG41704, isoform CRA_b) Apolipoprotein B mRNA editing enzyme catalytic subunit 3D |
Synonyms | bK150C2.9 hCG_41704 APOBEC3DE |
Description | FUNCTION: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms . Exhibits antiviral activity against HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA . The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Inhibits also the mobility of LTR and non-LTR retrotransposons . .; FUNCTION: (Microbial infection) Enhances hepatitis B virus/HBV replication by excluding restriction factors APOBEC3F and APOBEC3G from HBV capsids. . |
Accessions | Q96AK3 ENST00000427494.6 A0A087WX48 Q6ICH2 ENST00000622217.3 ENST00000216099.13 |